Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kosmos PLAX EF Pivotal Study

NCT07771231 is registered in ClinicalTrials.gov with EchoNous Inc. as lead sponsor.

NCT NCT07771231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07771231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kosmos PLAX EF Pivotal Study
Lead sponsor
EchoNous Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
May 5, 2026
Completion date
September 30, 2026
Enrollment
416 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ejection fraction, heart, heart failure, left ventricular ejection fraction, left ventricular ejection fraction less then or equal to 50percent